Enabling Precision Medicine Through AI

Enjoy the following content from our partner, Fabric Genomics. Precision medicine is of growing interest for healthcare providers and hospitals. The Precision Medicine Initiative defined precision medicine as an "emerging approach for disease prevention and treatment that takes into account people's individual variations in genes, environment, and lifestyle." At...

Read


IDC Makes the Case for Purpose-Built Revenue Cycle Management Solutions

In September, International Data Corporation (IDC) released a new white paper, “Making a Case for Purpose-Built RCM: How Actionable Data and Lab Visibility Benefits Health Systems.” In this paper, IDC research director, Mutaz Shegewi outlines the many reasons that a laboratory-specific revenue cycle management (RCM) system is the best choice for hospital and health system outreach laboratories.In...

Read


How to Succeed as CIO in the New Decade

Enjoy the following content from our customer, Sonora Quest Laboratories. Have you ever wondered about the real meaning and purpose of a Chief Information Officer (CIO)? In today’s complex technological environment, it can have many meanings and require diverse expertise as will be shown in this blog post. Initially, however, the CIO role and title was created in...

Read


The Ugly Truth About Payors and PAMA

Recently CAP Today provided an excellent recap of XIFIN CEO and Executive Chairman, Lâle White's Executive War College presentation "Ugly Truth about Payors & PAMA: What Labs Can Expect and How to Respond." In this blog post, we break down some of the key points: PAMA Is a Price Reduction ProgramContrary to its publicized goal of achieving market-based pricing, the government...

Read


United Healthcare Reimbursement Policy Update for Molecular Pathology

United Healthcare announced that the effective date of their reimbursement policy update for molecular pathology has moved from dates of service beginning September 1, 2019, to dates of service beginning November 1, 2019.This reimbursement policy change affects claims submitted with codes for Tier 1 and Tier 2 Molecular Pathology. Tier 2 Molecular Pathology codes are 81400 – 81408, and are to be...

Read


Understanding Trends in Denials & Patient Responsibility

A XIFIN analysis of aggregated client data and denial trends reveals billing policy changes are impacting laboratory financials and patient out-of-pocket expenses. Without proper workflow automation, increased denials are also impacting back-office productivity.Over the last eight years, the diagnostics industry has realized a significant decrease in revenue due to numerous reimbursement cuts....

Read


XIFIN RPM Helps Lab Outreach Business Grow Collections by 15%

Mona Dinnauer is the Laboratory Director, Outreach Services, at MercyOne Des Moines Laboratory, which is part of Des Moines Medical Center. The facility was founded in 1893 and is the longest continually operating hospital in Des Moines, Iowa, and is a member of the MercyOne network, a collaboration of CommonSpirit Health and Trinity Health.The laboratory's full-service outreach business started...

Read


Black Book Market Research Survey Shows Sharp Rise in Clinical Outsourcing Partnerships

Are you thinking of outsourcing your billing and revenue cycle? Well, you're not alone — A recent Black Book Market Research survey reveals a sharp increase in clinical outsourcing partnerships due to the pressures of value-based care reforms.The survey said the top two reasons for outsourcing services are cost savings/avoidance (selected by 85% of respondents) and the expertise of the...

Read